Literature DB >> 2076714

Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.

H Knauf1, E Mutschler.   

Abstract

The effects of torasemide have been studied in 7 healthy controls and 9 patients with stable chronic renal failure of various degrees. After a control period of 3 days torasemide 20 mg i.v. caused a dramatic increase in diuresis and electrolyte excretion without affecting the glomerular filtration rate. The duration of action of torasemide, tau, averaged 6 h and was independent of the creatinine clearance, CLCR. When related to tau the drug-induced excretion of Cl-, Na+, K+, Ca2+ and Mg2+ showed strong linear dependence on CLCR. Both the kaliuresis and the calciuresis during tau were tightly correlated with the natriuresis over the broad range of CLCR. Similarly, the excretion of Mg2+ was dependent on the kaliuresis. The torasemide-induced kaliuresis amounted to 12% of natriuresis, as after furosemide. The kaliuretic effect of loop diuretics is smaller than that of the thiazides. After tau, e.g. over a 24 h period, kaliuresis was not correlated with natriuresis. The magnitude of the rebound effect was diminished with increasing renal impairment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076714     DOI: 10.1007/BF00315406

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  29 in total

1.  Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure.

Authors:  H Spahn; H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency.

Authors:  L Dodion; J L Willems
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 3.  The renal excretion of calcium: a review of micropuncture data.

Authors:  R A Sutton; J H Dirks
Journal:  Can J Physiol Pharmacol       Date:  1975-12       Impact factor: 2.273

4.  Sodium homeostasis in chronic renal disease.

Authors: 
Journal:  Kidney Int       Date:  1982-06       Impact factor: 10.612

5.  The role of volume contraction in the hypocalciuric action of chlorothiazide.

Authors:  N Breslau; A M Moses; I M Weiner
Journal:  Kidney Int       Date:  1976-08       Impact factor: 10.612

6.  Pharmacokinetics and metabolism of torasemide in man.

Authors:  G Neugebauer; E Besenfelder; E von Möllendorff
Journal:  Arzneimittelforschung       Date:  1988-01

7.  Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 8.  Calcium transport in the nephron.

Authors:  W N Suki
Journal:  Am J Physiol       Date:  1979-07

9.  Clinical pharmacology of torasemide, a new loop diuretic.

Authors:  D C Brater; J Leinfelder; S A Anderson
Journal:  Clin Pharmacol Ther       Date:  1987-08       Impact factor: 6.875

10.  Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.

Authors:  E Keller; G Hoppe-Seyler; R Mumm; P Schollmeyer
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more
  12 in total

1.  Constant K+/Na+ excretion ratio during peak diuresis after piretanide but insignificant K+ loss during 24 hours.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Pharmacodynamic and kinetic considerations on diuretics as a basis for differential therapy.

Authors:  H Knauf; E Mutschler
Journal:  Klin Wochenschr       Date:  1991-04-04

3.  Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure.

Authors:  H Spahn; H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion.

Authors:  H Knauf; E Wenk; J Schölmerich; K J Goerg; W Gerok; H G Leser; E Mutschler
Journal:  Klin Wochenschr       Date:  1990-06-05

5.  The saluretic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rate.

Authors:  H Knauf; W Cawello; G Schmidt; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

6.  The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects.

Authors:  H Knauf; M A Bailey; G Hasenfuss; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  2006-09-09       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics and pharmacodynamics of torasemide.

Authors:  H Knauf; E Mutschler
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

Review 8.  Torasemide. An update of its pharmacological properties and therapeutic efficacy.

Authors:  C J Dunn; A Fitton; R N Brogden
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

Review 9.  Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis.

Authors:  H Knauf; E Mutschler; H Velazquez; G Giebisch
Journal:  Eur J Clin Pharmacol       Date:  2009-02-20       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.